About MME
MME is a Healthcare company based in Oxford (United States) founded in 2002, and was acquired by Indegene in August 2021. Marketing services to the pharmaceutical industry are provided. Its chief executive, as recorded, is Jack Mycka. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.
Company details
MME was established in 2002 and is based in Oxford, United States. Services in marketing and advisory support are delivered to clients within the pharmaceutical sector. Operations encompass strategic planning, promotional strategies, and compliance-focused communications for pharmaceutical products. Leadership is held by Jack Mycka, serving as CEO and President. The focus remains on facilitating effective market engagement for industry participants.
- Headquarters Oxford, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mmeadvisors.com
- Social LinkedIn X Facebook
- Acquired by Indegene (Aug 2021)
Investors in MME
MME has secured backing from 1 investor. Prominent investors backing the company include Indegene.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | indegene.com | Princeton, United States |
Investor details for MME
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MME
1 people are tracked at MME (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jack Mycka | CEO & President | Leadership |
Complete people profiles for MME
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MME
2 dated milestones of MME across 19 years, from founding to its latest funding, stage changes and deals.
- Founded MME is founded.
- Exit Acquired by Indegene.
Competitors of MME
MME has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| statinmed.com | 2007 | Ann Arbor, United States | Healthcare data analytics services provider |
Detailed competitors of MME
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as MME (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mme
Complete news archive for MME
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MME
MME was founded in 2002.
MME is headquartered in Oxford, United States.
Jack Mycka is the CEO of MME, as recorded in our data.
MME was established in 2002 and is based in Oxford, United States. Services in marketing and advisory support are delivered to clients within the pharmaceutical sector. Operations encompass strategic planning, promotional strategies, and compliance-focused communications for pharmaceutical products. Leadership is held by Jack Mycka, serving as CEO and President. The focus remains on facilitating effective market engagement for industry participants.
MME's top competitors include Target RWE, STATinMED Research and Secura Bio.
MME has 1 investor. Key investors include Indegene.
Yes. MME was acquired by Indegene in August 2021.